Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability.

Federico S, Khan T, Fontana A, Brogi S, Benedetti R, Sarno F, Carullo G, Pezzotta A, Saraswati AP, Passaro E, Pozzetti L, Papa A, Relitti N, Gemma S, Butini S, Pistocchi A, Ramunno A, Vincenzi F, Varani K, Tatangelo V, Patrussi L, Baldari CT, Saponara S, Gorelli B, Lamponi S, Valoti M, Saccoccia F, Giannaccari M, Ruberti G, Herp D, Jung M, Altucci L, Campiani G

Open source

DOI
10.1016/j.ejmech.2022.114409
Published
2022 Aug 5
Container
European journal of medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2022.114409,
  title = {Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability.},
  author = {Federico S and Khan T and Fontana A and Brogi S and Benedetti R and Sarno F and Carullo G and Pezzotta A and Saraswati AP and Passaro E and Pozzetti L and Papa A and Relitti N and Gemma S and Butini S and Pistocchi A and Ramunno A and Vincenzi F and Varani K and Tatangelo V and Patrussi L and Baldari CT and Saponara S and Gorelli B and Lamponi S and Valoti M and Saccoccia F and Giannaccari M and Ruberti G and Herp D and Jung M and Altucci L and Campiani G},
  year = {2022},
  journal = {European journal of medicinal chemistry},
  doi = {10.1016/j.ejmech.2022.114409},
  url = {https://doi.org/10.1016/j.ejmech.2022.114409}
}

RIS

TY  - JOUR
TI  - Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability.
AU  - Federico S
AU  - Khan T
AU  - Fontana A
AU  - Brogi S
AU  - Benedetti R
AU  - Sarno F
AU  - Carullo G
AU  - Pezzotta A
AU  - Saraswati AP
AU  - Passaro E
AU  - Pozzetti L
AU  - Papa A
AU  - Relitti N
AU  - Gemma S
AU  - Butini S
AU  - Pistocchi A
AU  - Ramunno A
AU  - Vincenzi F
AU  - Varani K
AU  - Tatangelo V
AU  - Patrussi L
AU  - Baldari CT
AU  - Saponara S
AU  - Gorelli B
AU  - Lamponi S
AU  - Valoti M
AU  - Saccoccia F
AU  - Giannaccari M
AU  - Ruberti G
AU  - Herp D
AU  - Jung M
AU  - Altucci L
AU  - Campiani G
PY  - 2022
JO  - European journal of medicinal chemistry
DO  - 10.1016/j.ejmech.2022.114409
UR  - https://doi.org/10.1016/j.ejmech.2022.114409
ER  - 

APA

S, F., T, K., A, F., S, B., R, B., F, S., G, C., A, P., AP, S., E, P., L, P., A, P., N, R., S, G., S, B., A, P., A, R., F, V., K, V., V, T., L, P., CT, B., S, S., B, G., S, L., M, V., F, S., M, G., G, R., D, H., M, J., L, A., & G, C. (2022). Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2022.114409

Source records